Skip to main content

Eco-Growth Strategies Inc. (ECGS)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
35.6Poor

ValueMarkers Composite Index

Top 2%#44,016 of 44,707

DCF data not available

Piotroski
3/9
Weak
Beneish
-
Altman
-39.07
Distress
DCF Value
-
N/A
ROIC
55.5%
Strong
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Eco-Growth Strategies Inc. (ECGS) — VMCI valuation read

ECGS prints VMCI 36/100 inside the Healthcare sector, where the median sits at 50. The 14-point below-median delta is the cleanest single-number summary of Eco-Growth Strategies Inc.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On ECGS, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** ECGS trades at 16.0x earnings, 11% below the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 0.1x leaves covenant headroom; that is the risk line for Eco-Growth Strategies Inc. on the trailing financials.

ECGS rose 3.4% over the trailing 7 days, with a -23.1% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in ECGS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.